Hope Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Kadima Neuropsychiatry Institute as the Expected First Acquisition for its International Network of Interventional Psychiatry Clinics
Kadima Neuropsychiatry Institute in La Jolla, CA to serve as flagship for an international network of clinics dedicated to treating depression and PTSD Kadima’s... Read more.
MulticoreWare and Cipia will showcase Next-Gen 60GHz Radar and Camera Fusion Powered In-Cabin Monitoring System at CES 2025
SAN JOSE, Calif., Jan. 2, 2025 /PRNewswire/ — MulticoreWare, Inc. a global technology company offering software solutions & engineering services and Cipia... Read more.
Rembrand Announces $23 Million Series A Financing Round Led by super{set}, Joining The Trade Desk, Naver Corporation, & Existing Investors
Funding represents support for the growth of In-Scene Media and Virtual Product Placement across more content types (including professional CTV content) and more... Read more.
SouthState Closes Merger with Independent Financial
Expands Presence in TX & CO and Adds Three Board Members WINTER HAVEN, Fla., Jan. 2, 2025 /PRNewswire/ — SouthState Corporation (NYSE: SSB) (“SouthState”... Read more.
Cango Inc. Announces December 2024 Production Update for Crypto Mining Business
SHANGHAI, Jan. 2, 2025 /PRNewswire/ — Cango Inc. (NYSE: CANG) (“Cango” or the “Company”), a leading automotive transaction service... Read more.
Mitchell Humphrey Helps New Jersey Communities Stay Compliant with New DCA Mandate
Community development software provider makes online housing inspection requests easy for New Jersey municipalities with digital solutions. ST LOUIS, Jan. 2, 2025... Read more.
A speckle of hope for cancer patients
COLD SPRING HARBOR, N.Y., Jan. 2, 2025 /PRNewswire/ — Fighting cancer can seem like a deadly game of chance. While some patients may respond well to certain... Read more.
Veeda Group Rebrands as ‘Veeda Lifesciences’
AHMEDABAD, India, Jan. 2, 2025 /PRNewswire/ — Veeda Group has unveiled a new logo and brand identity—Veeda Lifesciences—marking a key milestone in its... Read more.
WuXi Biologics Ranks Top in 2024 Dow Jones Sustainability Indices for Second Consecutive Year
Named for second consecutive year named to prestigious DJSI list Leading green biologics solutions for a healthier future SHANGHAI, Jan. 2, 2025 /PRNewswire/ —... Read more.
Fapon Biopharma Introduces FP008 at Biotech Showcase: A Safer and More Effective Immunotherapy for Refractory Cancers
SAN FRANCISCO, Jan. 2, 2025 /PRNewswire/ — Fapon Biopharma, an innovator in developing therapeutic antibodies and fusion proteins, will present its latest... Read more.